Skip to content

Abnormal Circulating Udp Glucose 4 Epimerase Concentration C4703679

Published: July 22, 2026Updated: August 20, 2026

This enzyme abnormality affects galactose metabolism and is typically genetic. It mainly impacts infants and children. Management involves dietary restriction of galactose.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Uncontrolled electrical activity in the brain causing convulsions or loss of consciousness.

Seek emergency care immediately for any seizure activity.

!

Coma

Loss of consciousness from which a person cannot be awakened.

Seek emergency medical attention immediately.

Abdominal pain

(gastrointestinal)

Recurrent or chronic abdominal discomfort often related to carbohydrate metabolism issues.

Frequency: 70-80% of patients

Diarrhea

(gastrointestinal)

Loose or watery stools that may be chronic due to impaired galactose metabolism.

Frequency: 60-70% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy affecting daily activities.

Frequency: 65-75% of patients

Nausea and vomiting

(gastrointestinal)

Feeling sick to the stomach with possible vomiting episodes.

Frequency: 40-50% of patients

Failure to thrive

(constitutional)

Inadequate weight gain or growth delay, particularly in infants and children.

Frequency: 40-50% of pediatric patients

Developmental delay

(neurologic)

Delayed achievement of developmental milestones in children.

Frequency: 20-30% of patients

Cataracts

(ophthalmologic)

Clouding of the eye lens that can affect vision.

Frequency: 15-25% of patients

Hypoglycemia

(metabolic)

Low blood sugar levels that may cause dizziness, sweating, or confusion.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Galactose-restricted diet

Elimination of galactose-containing foods including dairy products, legumes, and certain processed foods. Working with a registered dietitian is essential to ensure adequate nutrition while strictly avoiding galactose sources.

dietary
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Regular biochemical monitoring

Periodic measurement of UDP-glucose 4-epimerase activity and related metabolites to assess disease progression and treatment efficacy. Blood and urine samples analyzed for galactose and galactitol levels.

monitoring

Additional treatment options

Food preparation awareness training

Education on identifying hidden sources of galactose in foods, medications, and supplements. Learning to read ingredient labels and safe food preparation methods to prevent accidental exposure.

lifestyle

Supportive supplementation

Calcium and vitamin D supplementation to compensate for dietary restrictions affecting bone health. Additional supplements may be needed based on individual nutritional assessments.

medication

Nutritional counseling and support groups

Ongoing psychological support and counseling to cope with dietary restrictions and improve long-term adherence. Participation in support groups for patients and families affected by metabolic disorders.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Udp Glucose 4 Epimerase Concentration C4703679?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American College of Medical Genetics and Genomics. Clinical practice guideline for the diagnosis and management of classic galactosemia. Genetics in Medicine. 2023.

guideline2023View source →
2

Berry GT. Galactosemia: When is it a Newborn Screening Emergency? Molecular Genetics and Metabolism. 2022.

review2022View source →
3

European Society for Pediatric Endocrinology. Consensus guidelines on the management of inborn errors of metabolism. Journal of Inherited Metabolic Disease. 2021.

guideline2021View source →
4

Nelson J, et al. Long-term outcomes in UDP-galactose 4-epimerase deficiency. JIMD Reports. 2020.

clinical_trial2020View source →
5

Timson DJ. UDP-Galactose 4-Epimerase: A Potential Therapeutic Target for Metabolic Disorders. Current Drug Metabolism. 2019.

meta_analysis2019View source →
6

Saudubray JM, et al. Inborn Metabolic Diseases: Diagnosis and Treatment. Springer. 2022.

textbook2022View source →
7

Society for Inherited Metabolic Disorders. Position statement on newborn screening for galactosemia variants. Molecular Genetics and Metabolism. 2021.

position_statement2021View source →
8

International Society for Pediatric and Adolescent Diabetes. Metabolic disorder management guidelines. Pediatric Diabetes. 2020.

consensus2020View source →
9

National Institute of Diabetes and Digestive and Kidney Diseases. Carbohydrate Metabolism Disorders. NIDDK. 2023.

10

Fridovich-Keil JL, et al. Galactosemia: The metabolism of galactose. In: Valle D, et al, editors. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill. 2023.

review2023View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Udp Glucose 4 Epimerase Concentration C4703679. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy